Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Neuroscience ; 155(4): 1227-36, 2008 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-18652880

RESUMO

Reg-2 is a secreted protein that is expressed de novo in motoneurons, sympathetic neurons, and dorsal root ganglion (DRG) neurons after nerve injury and which can act as a Schwann cell mitogen. We now show that Reg-2 is also upregulated by DRG neurons in inflammation with a very unusual expression pattern. In a rat model of monoarthritis, Reg-2 immunoreactivity was detected in DRG neurons at 1 day, peaked at 3 days (in 11.6% of DRG neurons), and was still present at 10 days (in 5%). Expression was almost exclusively in the population of DRG neurons that expresses the purinoceptor P2X(3) and binding sites for the lectin Griffonia simplicifolia IB4, and which is known to respond to glial cell line-derived neurotrophic factor (GDNF). Immunoreactivity was present in DRG cell bodies and central terminals in the dorsal horn of the spinal cord. In contrast, very little expression was seen in the nerve growth factor (NGF) responsive and substance P expressing population. However intrathecal delivery of GDNF did not induce Reg-2 expression, but leukemia inhibitory factor (LIF) had a dramatic effect, inducing Reg-2 immunoreactivity in 39% of DRG neurons and 62% of P2X(3) cells. Changes in inflammation have previously been observed predominantly in the neuropeptide expressing, NGF responsive, DRG neurons. Our results show that changes also take place in the IB4 population, possibly driven by members of the LIF family of neuropoietic cytokines. In addition, the presence of Reg-2 in central axon terminals implicates Reg-2 as a possible modulator of second order dorsal horn cells.


Assuntos
Artrite Experimental/patologia , Gânglios Espinais/patologia , Expressão Gênica/fisiologia , Litostatina/metabolismo , Neurônios/metabolismo , Animais , Expressão Gênica/efeitos dos fármacos , Fator Neurotrófico Derivado de Linhagem de Célula Glial/metabolismo , Indóis , Lectinas/metabolismo , Fator Inibidor de Leucemia/farmacologia , Masculino , Proteínas Proto-Oncogênicas c-ret/metabolismo , Ratos , Ratos Wistar , Receptor trkA/metabolismo , Receptores Purinérgicos P2/metabolismo , Receptores Purinérgicos P2X3 , Substância P/metabolismo , Fatores de Tempo
2.
J Neurosci ; 21(18): 7161-70, 2001 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-11549727

RESUMO

Conditioning injury to adult mammalian sensory neurons enhances their regeneration potential. Here we show that leukemia inhibitory factor (LIF) is a fundamental component of the conditioning response. Conditioning injury in vivo significantly increases the intrinsic growth capacity of sensory neurons in vitro from LIF+/+ mice. This conditioning effect is significantly blunted in sensory neurons from LIF-/- mice. Enhanced growth is rescued in vitro in LIF-/- mice by the addition of exogenous LIF, and the effect blocked by human LIF-05, an LIF receptor antagonist. Furthermore, we demonstrate that LIF promotes elongating but not arborizing neurite outgrowth in vitro and is required for normal regeneration of injured adult sensory neurons in vivo. LIF is also functionally protective to peptidergic sensory neurons after nerve damage in vivo. Our results indicate that the alteration in intrinsic growth status of injured sensory neurons depends, at least in part, on LIF.


Assuntos
Inibidores do Crescimento/metabolismo , Interleucina-6 , Linfocinas/metabolismo , Neurônios Aferentes/metabolismo , Animais , Axotomia , Peptídeo Relacionado com Gene de Calcitonina/biossíntese , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Citoproteção/efeitos dos fármacos , Feminino , Gânglios Espinais/citologia , Gânglios Espinais/efeitos dos fármacos , Inibidores do Crescimento/administração & dosagem , Inibidores do Crescimento/genética , Injeções Espinhais , Fator Inibidor de Leucemia , Linfocinas/administração & dosagem , Linfocinas/genética , Masculino , Camundongos , Camundongos Knockout , Fibras Nervosas/metabolismo , Regeneração Nervosa/efeitos dos fármacos , Regeneração Nervosa/fisiologia , Neuritos/efeitos dos fármacos , Neuritos/fisiologia , Neurônios Aferentes/citologia , Neurônios Aferentes/efeitos dos fármacos , Fenótipo , Ratos , Ratos Wistar , Nervo Isquiático/fisiologia , Nervo Tibial/fisiologia
3.
Eur J Neurosci ; 12(3): 793-802, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10762308

RESUMO

The neuropeptide galanin has been identified as a potential neurotransmitter/neuromodulator within the central nervous system. In the present study, the role of endogenous galanin in nociceptive processing in the nervous system has been analysed by using mice carrying a targeted mutation in the galanin gene. Supporting this, the effect of chronic administration of exogenous galanin on nociceptive sensory inputs has been assayed in adult rats. In the absence of peripheral nerve injury, the sensitivity to threshold noxious stimuli is significantly higher in galanin mutant mice than wild-type controls. Following peripheral nerve injury, in conditions under which endogenous galanin levels are elevated, spontaneous and evoked neuropathic pain behaviours are compromised in mutant mice. Conversely, chronic intrathecal delivery of exogenous galanin to nerve-intact adult rats is associated with persistent behavioural hypersensitivity, a significant increase in c-fos expression and an increase in PKCgamma immunoreactivity within the spinal cord dorsal horn. The present results demonstrate that a relationship exists between the degree of nerve injury-induced galanin expression and the degree of behavioural hypersensitivity, and show that galanin may play a role in nociceptive processing in the spinal cord, with interrelated inhibitory and excitatory effects.


Assuntos
Galanina/fisiologia , Nociceptores/fisiologia , Traumatismos dos Nervos Periféricos , Animais , Comportamento Animal/efeitos dos fármacos , Galanina/genética , Galanina/farmacologia , Temperatura Alta , Hiperalgesia/fisiopatologia , Imuno-Histoquímica , Injeções Espinhais , Isoenzimas/biossíntese , Masculino , Camundongos , Camundongos Knockout , Medição da Dor/efeitos dos fármacos , Limiar da Dor/efeitos dos fármacos , Estimulação Física , Proteína Quinase C/biossíntese , Proteínas Proto-Oncogênicas c-fos/biossíntese , Ratos , Ratos Wistar , Medula Espinal/efeitos dos fármacos , Medula Espinal/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA